Fund shareholders of Pacific Biosciences of California Inc
ISIN US69404D1081 · United States · LEI 529900F1BWRE1M0KZN89
- Fund shareholders
- 129
- Of which ETFs
- 32 97 other funds
- Value held
- 106M $
- Share of capital
- 22.9 % of 310.8M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 9,600 | 12.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 9,113 | 14.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 8,898 | 14.9K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Core Equity 2 ETF Dimensional ETF Trust | 8,144 | 12.9K $ | 0.00 % | as of Apr 30, 2026 ↗ | |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 8,100 | 10.7K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 8,085 | 12.9K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 1 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 7,862 | 10.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| LVIP Dimensional U.S. Core Equity 2 Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 7,405 | 9.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 6,977 | 9.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 6,559 | 8.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| JNL/DFA U.S. Core Equity Fund JNL Series Trust | 5,500 | 7.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Flex Small Cap Focused Index Fund Fidelity Salem Street Trust | 5,204 | 8.3K $ | 0.05 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 4,940 | 6.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 4,371 | 5.8K $ | 0.25 % | 0.00 % | as of Mar 31, 2026 ↗ |
| EQ/Common Stock Index Portfolio EQ Advisors Trust | 3,200 | 4.2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 3,116 | 5K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 1,744 | 2.3K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 1,589 | 2.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Equity Fund American Century ETF Trust | 1,486 | 2.5K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 1,408 | 1.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 923 | 1.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP SMALL CAP ProFunds | 698 | 921.4 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 623 | 822.4 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 504 | 801.4 $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 416 | 549.1 $ | 0.02 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 384 | 506.9 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 283 | 475.4 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 86 | 144.5 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 71 | 93.7 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| ARK Genomic Revolution ETF ARK ETF Trust | 1.41 % | as of Apr 30, 2026 ↗ |
| AltShares Event-Driven ETF AltShares Trust | 0.72 % | as of Feb 28, 2026 ↗ |
| Water Island Event-Driven Fund ARBITRAGE FUNDS | 0.52 % | as of Feb 28, 2026 ↗ |
| American Beacon ARK Transformational Innovation Fund AMERICAN BEACON FUNDS | 0.48 % | as of Mar 31, 2026 ↗ |
| iShares Genomics Immunology and Healthcare ETF iShares Trust | 0.48 % | as of Apr 30, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 0.38 % | as of Feb 28, 2026 ↗ |
| ARK Innovation ETF ARK ETF Trust | 0.36 % | as of Apr 30, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.34 % | as of Feb 28, 2026 ↗ |
| AXS Green Alpha ETF INVESTMENT MANAGERS SERIES TRUST II | 0.32 % | as of Mar 31, 2026 ↗ |
| WisdomTree BioRevolution Fund WisdomTree Trust | 0.25 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 129 | +11 | 71,107,144 | -4.1 % |
| 2026Q1 | 118 | +12 | 74,129,033 | +3.7 % |
| 2025Q4 | 106 | 0 | 71,499,450 | -6.1 % |
| 2025Q3 | 106 | -12 | 76,149,329 | -2.3 % |
| 2025Q2 | 118 | -8 | 77,944,945 | -4.2 % |
| 2025Q1 | 126 | -3 | 81,337,523 | -3.3 % |
| 2024Q4 | 129 | -27 | 84,142,607 | -9.9 % |
| 2024Q3 | 156 | -43 | 93,396,337 | -17.9 % |
| 2024Q2 | 199 | -27 | 113,753,948 | +1.1 % |
| 2024Q1 | 226 | -16 | 112,486,924 | +3.5 % |
| 2023Q4 | 242 | 108,681,418 |
Institutional managers
225 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| ARK Investment Management LLC | 36,273,288 | 47.9M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 25,267,429 | 33.4M $ | as of Mar 31, 2026 |
| SOFTBANK GROUP CORP. | 20,451,570 | 27M $ | as of Mar 31, 2026 |
| Sumitomo Mitsui Trust Group, Inc. | 7,037,987 | 9.3M $ | as of Mar 31, 2026 |
| Amova Asset Management Americas, Inc. | 7,037,987 | 9.2M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 6,975,266 | 9.2M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 6,121,716 | 8.1M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 4,892,318 | 6.5M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 3,637,547 | 4.8M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 3,509,613 | 4.6M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 2,950,929 | 3.9M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 2,489,100 | 3.3M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2,405,496 | 3.2M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 2,130,788 | 2.8M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,840,461 | 2.4M $ | as of Mar 31, 2026 |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 1,788,393 | 2.4M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,719,165 | 2.3M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,666,706 | 2.2M $ | as of Mar 31, 2026 |
| UBS Group AG | 1,640,099 | 2.2M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 1,576,051 | 2.1M $ | as of Mar 31, 2026 |
| Birchview Capital, LP | 1,500,000 | 2M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,468,148 | 1.9M $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 1,390,070 | 1.8M $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 1,265,535 | 1.7K $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 1,184,975 | 1.6M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of Pacific Biosciences of California Inc". https://titelia.com/en/stocks/pacific-biosciences-of-california-inc-US69404D1081